Trastuzumab and Flavopiridol in Treating Patients With Metastatic Breast Cancer

Clinical trial NCT00039455 · TERMINATED

Trial details

NCT number: NCT00039455
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

HER2-positive Breast Cancer Male Breast Cancer Recurrent Breast Cancer Stage IV Breast Cancer

Start date: 2002-04-01
Primary completion: 2004-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.